Selected Grantee Publications
A New Drosophila melanogaster Research Resource: CRISPR-Induced Mutations for Clonal Analysis of Fourth Chromosome Genes
Weasner et al., G3 (Bethesda). 2025.
https://pubmed.ncbi.nlm.nih.gov/39804955
The fruit fly, Drosophila melanogaster, shares approximately 60% of its genes with human homologs and is an excellent model organism for studying mechanisms underlying human health and disease. However, the fourth chromosome of this organism is challenging to study because of the lack of genetic resources. This study presents a new resource—the Fourth Chromosome Resource Project—for studying the fourth chromosome of the fruit fly and expanding the understanding of gene function and disease mechanisms. Using gene editing approaches, researchers generated and characterized 119 mutations in 62 fourth chromosome genes, including 84 predicted null alleles and 29 in-frame deletions. Phenotypic assessments included tests for lethality, sterility, and visible traits. Many stable mutant stocks were submitted into public repositories in the United States and Japan for research purposes. Supported by ORIP (P40OD018537, R24OD028242) and NHGRI.
Suppressing APOE4-Induced Neural Pathologies by Targeting the VHL-HIF Axis
Jiang et al., PNAS. 2025.
https://pubmed.ncbi.nlm.nih.gov/39874294
The ε4 variant of human apolipoprotein E (APOE4) is a major genetic risk factor for Alzheimer’s disease and increases mortality and neurodegeneration. Using Caenorhabditis elegans and male APOE-expressing mice, researchers determined that the Von Hippel-Lindau 1 (VHL-1) protein is a key modulator of APOE4-induced neural pathologies. This study demonstrated protective effects of the VHL-1 protein; the loss of this protein reduced APOE4-associated neuronal and behavioral damage by stabilizing hypoxia-inducible factor 1 (HIF-1), a transcription factor that protects against cellular stress and injury. Genetic VHL-1 inhibition also mitigated cerebral vascular injury and synaptic damage in APOE4-expressing mice. These findings suggest that targeting the VHL–HIF axis in nonproliferative tissues could reduce APOE4-driven mortality and neurodegeneration. Supported by ORIP (R24OD010943, R21OD032463, P40OD010440), NHGRI, NIA, and NIGMS.
Identification of Constrained Sequence Elements Across 239 Primate Genomes
Kuderna et al., Nature. 2024.
https://pubmed.ncbi.nlm.nih.gov/38030727/
Functional genomic elements that have acquired selective constraints specific to the primate order are prime candidates for understanding evolutionary changes in humans, but the selective constraints specific to the phylogenetic branch from which the human species ultimately emerged remain largely unidentified. Researchers constructed a genome-wide multiple sequence alignment of 239 primate species to better characterize constraint at noncoding regulatory sequences in the human genome. Their work reveals noncoding regulatory elements that are under selective constraint in primates but not in other placental mammals and are enriched for variants that affect human gene expression and complex traits in diseases. These findings highlight the important role of recent evolution in regulatory sequence elements differentiating primates, including humans, from other placental mammals. Supported by ORIP (P40OD024628), NHGRI, NIA, and NICHD.
Multiplexed Drug-Based Selection and Counterselection Genetic Manipulations in Drosophila
Matinyan et al., Cell Reports. 2021.
https://www.cell.com/cell-reports/pdf/S2211-1247(21)01147-5.pdf
Many highly efficient methods exist which enable transgenic flies to contribute to diagnostics and therapeutics for human diseases. In this study, researchers describe a drug-based genetic platform with four selection and two counterselection markers, increasing transgenic efficiency by more than 10-fold compared to established methods in flies. Researchers also developed a plasmid library to adapt this technology to other model organisms. This highly efficient transgenic approach significantly increases the power of not only Drosophila melanogaster but many other model organisms for biomedical research. Supported by ORIP (P40OD018537, P40OD010949, R21OD022981), NCI, NHGRI, NIGMS, and NIMH.